5.035EUR+1.47%Mkt Cap: 95.91M EURP/E: —Last update: 2026-05-14
Adocia SA, a clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic pr…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-12.18
PEG—
P/B-144.18
P/S24.92
EV/EBITDA—
EV/Revenue—
EPS (TTM)-0.90
EPS (Forward)-0.40
Cash Flow & Leverage
FCF Yield—
FCF Margin—
Operating CF-6.53M EUR
CapEx (TTM)267.00K EUR
Net Debt/EBITDA—
Net Debt—
Technical
SMA 505.073 (-0.7%)
SMA 2006.998 (-28.1%)
Beta0.27
S&P 52W Chg24.23%
Avg Vol (30d)278.65K
Avg Vol (10d)218.34K
Technical Indicators
RSI (14)52.0
MACD-0.0346
MACD Signal-0.0902
MACD Hist.+0.0556
BB Upper5.377 EUR
BB Middle4.877 EUR
BB Lower4.376 EUR
BB Width20.52%
ATR (14)0.3481 EUR
Vol Ratio (20d)0.89x
52W Range
3.30019% of range12.40
52W High12.40 EUR
52W Low3.300 EUR
Profitability
Gross Margin46.31%
EBITDA Margin0.00%
Profit Margin-1124.81%
Oper. Margin-414.25%
ROE-1112.74%
ROA-58.31%
Revenue Growth-84.60%
Earnings Growth—
Balance Sheet
Debt/Equity5.97
Current Ratio—
Quick Ratio—
Book Value/Sh-0.0340 EUR
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.19.57M
Float—
Insiders9.93%
Institutions8.18%
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)13.00 EUR
Target Range11.00 EUR – 16.00 EUR
# Analysts3
Company
Market Cap95.91M EUR
Enterprise Value—
Revenue (TTM)3.85M EUR
Gross Profit683.00K EUR
Net Income (TTM)-16.59M EUR
Revenue/Share—
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
Last Price5.035 EUR
CountryFR
SectorHealthcare
IndustryBiotechnology
ISIN—